LIFETEK SELECTS THE CLEARANT PROCESS TO ENSURE STERILITY FOR SOFT AND HARD TISSUE ALLOGRAFTS

Clearant, Inc. (OTCBB: CLRI), the developer of the patent protected CLEARANT PROCESS(R) for pathogen inactivation, announced today that LifeTek LLC, a leading biomaterials and biosurgical device company, has selected the CLEARANT PROCESS(R) to ensure sterility for both hard tissue allografts used in the orthopedic trauma market and soft tissue allografts used in the sports medicine market.

Reuters

http://today.reuters.com/stocks/QuoteCompanyNewsArticle.aspx?view=PR&symbol=CLRI&storyID=148283+04-Aug-2005+BW (http://www.rednova.com/news/health/196686/cantel_medical_acquires_specialist_in_infection_control/)